Lay summary
The research will assess the relationship among similar and disparate risk factors for various types of non-Hodgkin lymphoma (NHL) and variations in the gene controlling mechanisms that are passed on when cells divide. The NHL patient series will also provide a basis for survival studies for patients with different types of NHL and allow the impact of new types of therapy to be estimated.